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http://dx.doi.org/10.1016/j.jmii.2013Leptospirosis is caused by pathogenic bacteria called leptospires that are transmitted directly or
indirectly from animals to humans. It occurs worldwide but is most common in tropical and sub-
tropical areas. It is a potentially serious but treatable disease. Its symptomsmaymimic those of a
number of other unrelated infections such as influenza, meningitis, hepatitis, dengue, or other
viral hemorrhagic fevers. The spectrumof thedisease is extremelywide, ranging from subclinical
infection to a severe syndrome of multiorgan infection with high mortality. Laboratory diagnosis
tests are not always available, especially in developing countries. Numerous tests have been
developed, but availability of appropriate laboratory support is still a problem. Direct observa-
tion of leptospires by darkfield microscopy is unreliable and not recommended. Isolation of lep-
tospires can take up to months and does not contribute to early diagnosis. Diagnosis is usually
performed by serology; enzyme-linked immunosorbent assay and the microscopic agglutination
tests are the laboratory methods generally used, rapid tests are also available. Limitation of
serology is that antibodies are lacking at the acute phase of the disease. In recent years, several
real-time polymerase chain reaction assays have been described. These can confirm the diag-
nosis in the early phase of the disease prior to antibody titers are at detectable levels, but
molecular testing is not available in restricted resources areas.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
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.03.001Introduction
The clinical presentation of leptospirosis is unspecific,
misdiagnosis is frequent, and diagnosis is based upon lab-
oratory results. The laboratory diagnosis of leptospirosis is
challenging. The only sensitive and specific test accurate atished by Elsevier Taiwan LLC. All rights reserved.
246 D. Musso, B. La Scolathe acute phase of the disease is polymerase chain reaction
(PCR), which is not available in most high endemic
areas and the serological reference method by micro
agglutination testing (MAT) is restricted to reference labo-
ratories. In this review we present the advantages and
disadvantages of the laboratory methods for leptospirosis
diagnosis and we focus on the rapid tests currently used in
countries with low resources.
History
Adolf Weil reported the syndrome of icteric leptospirosis
with renal failure in 1886 but the disease was recognized
earlier as an occupational hazard of rice harvesting in
ancient China.1,2 Leptospires were first visualized in au-
topsy specimen from a patient thought to have had yellow
fever. The role of the rat as a source of human infection
was discovered in 1917.
Bacteriology
Leptospires belong to the order Spirochaetales, family
Leptospiraceae, genus Leptospira.3 They can be pathogenic
or saprophytic. Pathogenic leptospires can be maintained in
nature in the renal tubules of animals and saprophytic
leptospires in many types of wet or humid environments.
Classification of leptospires
Prior to 1989, the genus Leptospira was divided into two
species: Leptospira interrogans (pathogenic strains) and
Leptospira biflexa (saprophytic strains). The species were
divided into serovars and the serovars grouped into
serogroups. More than 24 serogroups and 250 serovars of
pathogenic leptospires have been described to date.4 The
serovar concept has been widely accepted because it has
someepidemiologic value, but it has no taxonomic standing.5
The serologic classification has been replaced by a
genotypic one. The genomospecies include all L. inter-
rogans and L. biflexa serovars. The genus Leptospira is
divided into 20 species classified into saprophytic, inter-
mediate, and pathogenic groups. The genomospecies of
Leptospira do not correspond to the previous species
L. interrogans and L. biflexa.
Epidemiology
Leptospirosis is the most widespread zoonosis in the world
and is considered as an emerging global public health
disease.6
It occurs worldwide with a higher incidence in warm
than in temperate regions. The number of severe human
cases worldwide is estimated above 500,000.7 Incidences
range from 0.1e1/100,000/year in temperate climates,
10e100/100,000/year in the humid tropics to over 100/
100,000/year during outbreaks and in high-exposure risk
groups. The endemicity of the disease is mainly located in
the Caribbean, Central and South America, Southeast Asia
and Oceania.8 During the past several years, large out-
breaks have occurred in many countries, particularly inSoutheast Asia, Central and South America. Case-fatality
rates range from <5% to 30%.
Effective surveillance systems with appropriate labora-
tory support exist in developed countries but are often
lacking in the disease-endemic developing areas. The re-
ported incidence of leptospirosis reflects the availability of
laboratory diagnosis and the clinical index of suspicion as
much as the incidence of the disease. For example, the
actual incidence of leptospirosis in the Asia Pacific region is
not well documented9 and leptospirosis is often under-
estimated.10 With the hyperendemic Southeast Asia zone,
Oceania exhibits a significant burden of leptospirosis. In the
Asia Pacific region, predominantly in developing countries,
leptospirosis is largely a water-borne disease.
Numerous animals, primarily mammals, are sources of
human infection. Rodents are the most important and
widely distributed reservoirs of leptospires. Some serovars
are associated with a particular species of natural main-
tenance host. In chronic infections, leptospires are local-
ized in the kidneys, usually without detectable clinical
manifestations.
The usual mode of contamination is abrasions or cuts in
the skin or via the conjunctiva through direct or indirect
contact with urine or tissues of infected animals. Other
modes of contamination, such as inhalation of water or
aerosols, animal bites, or interhuman transmission, have
been rarely demonstrated.
Leptospirosis is an occupational disease for veterinar-
ians, farmers, abattoir workers, butchers, hunters, rodent
control workers, and other occupations requiring contact
with animals. Indirect contact with contaminated wet soil
or water is responsible for the great majority of cases in the
tropics, either through occupational exposure as in rice or
taro farming, flooding after heavy rains, or exposure to
damp soil and water during avocational activities.
Contamination due to recreational exposures is increasing,
often in association with adventure tourism in tropical
endemic areas.
Three epidemiological patterns have been defined: in
temperate climates where few serovars are involved and
human infection occurs by direct contact with infected
animals; in tropical wet areas where there are many more
serovars infecting humans and animals and larger numbers
of reservoir species; and in the urban environment as a
rodent-borne infection.11Clinical presentation
It may range from a flu-like illness to a serious and some-
times fatal disease. Confusion with other diseases, espe-
cially dengue fever and other hemorrhagic fevers, is
frequent in the tropical areas. The mean incubation time is
1e2 weeks, with a range of 2 days to 30 days. The acute or
septicemic phase lasting about 1 week is followed by an
immune phase characterized by antibody production. The
great majority of infections are subclinical or of very mild
severity. The most common symptoms are febrile illness of
sudden onset, chills, headache, myalgia, abdominal pain,
and conjunctival suffusion. Other clinical presentations
may be predominant, in addition to hepatic or renal
dysfunction, leptospirosis should be seriously considered in
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subtropical and tropical areas, as reported in a retrospec-
tive study conducted in Taiwan.12
Laboratory diagnosis
Specimen collection
Several blood tubes should be collected at the early phase
of the disease: standard blood culture bottle or tube;
nonadditive or gel separator tubes for chemistry and
serology; and EDTA tube for blood count.
For blood culture, blood with heparin to prevent clotting
is recommended but ideally blood is inoculated directly
into blood culture bottles containing culture medium for
leptospires.
For molecular testing, published studies showed mixed
results13: serum was reported to be inferior to plasma14,15;
serum was reported to be superior to whole blood; and
buffy coat was reported to be superior to plasma and
serum.16 Heparin was reported to be inhibitory.17
All blood samples must be conserved for subsequent
additional testing. Acute blood samples are of great impor-
tance for serology in order to demonstrate a seroconversion.
Nonspecific laboratory findings
The various nondiagnostic abnormalities are reported in
Table 118; these can only suggest leptospirosis. Specific
microbiological tests are required for confirmation.
Microscopic demonstration
Leptospires cannot be observed under the ordinary light
microscope but by darkfield microscopy as thin, coiled, andTable 1 Nonspecific laboratory findings
1. Blood analysis
1.1. Leukocytosis with a shift to the left
1.2. Thrombocytopenia in >50%18
1.3. Elevated
1.3.1. Erythrocyte sedimentation rate
1.3.2. Creatinine (usually <20e80 mg/L)
1.3.3. Urea (usually <1000 mg/L)
1.3.4. Aminotransferases (rarely > 200 IU/L)
1.3.5. Bilirubin (may rise to 800 mg/L)
1.3.6. Alkaline phosphatase
2. Urine analysis
2.1. Proteinuria, pyuria, microscopic hematuria, hyaline,
and granular casts
3. Cerebrospinal fluid analysis
3.1. Normal or slightly elevated cerebrospinal fluid pressure
3.2. Initially a predominance of polymorphs or lymphocytes
(total cell counts generally <500  106/L) and
lymphocytes predominance later. Pleocytosis can persist
for weeks
3.3. Elevated protein (50e100 g/L)
3.4. Glucose is usually normal
3.5. Xanthochromia may occurrapidly moving microorganisms. Sensitivity of darkfield mi-
croscopy is approximately 107 leptospires/L. Direct exami-
nation of blood and urine has both low sensitivity and
specificity, it is subject to misinterpretation of fibrin or
protein threads, then is not recommended as a routine
procedure.
Leptospires are not stained by conventional Gram
staining. Available staining methods to increase the sensi-
tivity of direct examination are: immunofluorescence,
immunoperoxidase, silver staining, Warthin-Starry staining,
immunohistochemistry, and in situ hybridization. All of
these suffer from the same drawbacks as darkfield micro-
scopy: a high risk of false-positive and false-negative
results.
Isolation of leptospires
Samples for culture should be collected prior to the
administration of antibiotics. Blood, cerebrospinal fluid and
dialysate should be cultured in the first 10 days of the
illness, and urine from the second week of the illness.
Several specific media were described by Fletcher et al.
The most used medium is based on the oleic acid-albumin
Ellinghausen-McCullough-Johnson-Harris (EMJH) medium
(Becton Dickinson and Company, Difco) and is available
commercially.
Samples should be stored and transported at ambient
temperatures. Survival of leptospires in human urine is
limited so urine should be processed immediately. Cultures
are incubated in the dark at 28e30C and examined weekly
by darkfield microscopy for up to 13 weeks prior to being
discarded.
Antigen detection
Different antigen detection tests have been developed but
none of them is sensitive enough to be routinely used.19
Antibody detection
The MAT, which is the serological reference test, was first
described in 1918 by Martin and Pettit. Live antigens rep-
resenting different serogroups are reacted with serum
samples and the agglutination is examined by darkfield
microscopy. Panels of live leptospires belonging to different
serovars must be maintained in the laboratory. As a mini-
mum, the panel should include all locally circulating sero-
vars and, if these serovars are unknown or subject to
change, the panel should include serovars representing all
serogroups. An incomplete panel should be responsible for
false negative results. MAT may be positive from Day 10e12
after the onset of illness, sometimes later if specific anti-
biotics have been prescribed. MAT was reported to have a
sensitivity of 41% during the 1st week, 82% during the 2nd to
4th week, and 96% beyond the 4th week of illness.20 The cut
off value on a single sera depends from the seroprevalence.
For the Center for Disease Control, a probable case is
defined as a titer 200 associated with a clinically
compatible illness21; in a publication from the Center for
Disease Control of Taiwan, an antibody titer 100 was
regarded as a probable case of leptospirosis22; in a study
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single titer 400.23 The Leptospirosis Burden Epidemiology
Reference Group consider a single MAT 1:400 (or single
MAT 1:100 in nonendemic regions) to be consistent with
leptospirosis. A low titer is appropriate in a population in
which exposure to leptospirosis is uncommon but, if expo-
sure is frequent, as in most tropical countries, a higher cut-
off titer is necessary. In very high endemic areas, a single
titer of 800 in symptomatic patients is generally indicative
but a 1600 titer has been recommended. In cases of pre-
vious infection with a different serogroup, interpretation is
complicated by the “anamnestic response” (the rise in
antibody titer is directed against a previous infecting
serovar). A fourfold or greater rise in titer between paired
sera is required to confirm leptospirosis. MAT detects both
class M and class G antibodies, and cannot differentiate
between current, recent, or past infections. It may identify
the presumptive serogroup, and under the best conditions
the serovar because interpretation is complicated by the
high degree of cross-reaction that occurs between different
serogroups, especially in acute-phase samples.
The MAT is complex to control and perform; it cannot be
standardized because live leptospires are used as antigens.
Enzyme-linked immunosorbent assay (ELISA) detects
antibodies reacting with a broadly reactive genus-specific
antigen and thus is not suitable for identification of the
causative serovar or serogroup. Commercial kits are avail-
able. The cut-off point is determined on the same consid-
erations as for the MAT. Serogroups Grippotyphosa and
Australis gave false negative results. ELISA is usually posi-
tive from Day 6e8, earlier than the MAT, and it may be
negative earlier. Most of the commercial ELISA kits use as
antigen the nonpathogenic Leptospira biflexa patoc strain.
ELISA allows detection of specific IgM class antibodies. IgM
may remain detectable for several months or even years.
Positive ELISA should be confirmed by MAT.
Other serological tests have been developed: comple-
ment fixation, counterimmunoelectrophoresis, indirect
fluorescent antibody, indirect hemagglutination (IHA),
sensitized erythrocyte lysis, latex agglutination (LA),
macroscopic slide agglutination, microcapsule agglutina-
tion, and Patoc slide agglutination.
Rapid screening tests based on four immunological prin-
ciples are used: particle agglutination (centrifugation of
whole blood required, detection of a weak agglutination is
difficult, reagents often require refrigeration); immunodot
or dipstick/comb (results are visualized as a spot, dot, or
line, test requires less than 30 minutes to develop, reagents
do not require refrigeration); immunofiltration or flow-
through device (the assay require several steps, reagents
often require refrigeration); immunochromatography or
lateral flow (a visible line at test and control location in-
dicates a positive reaction, no special equipment required,
they are one step tests and are completedwithin 15minutes;
depending on the assay, whole blood, serum, or plasma can
be used, reagents do not require refrigeration).24Evaluation of rapid screening tests
Rapid tests are easy to use and can be performed by in-
dividuals without special technical training. Some of themcan be performed on whole blood and can be stored for
prolonged periods at ambient temperatures, and standard
laboratory equipment is not required. Even though the
reading and interpretation of rapid test reactions is claimed
to be simple, some training is required to perform and
interpret them correctly. Interobserver variability in
reading and interpretation of the end points may provide
inconsistent results.
These tests are primarily IgM detection assays, but
because IgM is not detectable until the second week after
symptom onset, they have low sensitivity in the early acute
phase of illness when patients present for medical
treatment.25
In a large multicenter evaluation of an IgM Leptospira
dipstick assay conducted in areas with high and low lepto-
spirosis endemicity, the mean sensitivity was 60.1% on sera
collected within the first 10 days of the illness and the re-
sults were concordant with an ELISA IgM.26
Four rapid tests (ELISA IgM, IHA, IgM dipstick assay, IgM
dot-ELISA dipstick test) were evaluated: the sensitivity
ranged from 38.5% (IHA) to 52.7% (IgM dipstick assay) on
acute sera collected prior to 14 days after onset of the
disease, by comparison, the sensitivity was 48.7% with
MAT.27 Sensitivity on convalescent sera ranged from 67.2%
to 84.4% and was 93.8% for MAT.
Eight rapid tests (IHA, 2 IgM dipstick assay; indirect
fluorescent antibody, 3 ELISA IgM, LA) have been evaluated
in Hawaii and the authors concluded that all tests were
insensitive for diagnosis within the first week of the disease
while it is during this time that important therapeutic de-
cisions are likely to be made.28 Evaluation of two rapid tests
at the acute visit for leptospirosis (IgM dipstick assay, LA)
and dengue (IgM dipstick assay, Dengue duo rapid strip) in a
tropical field setting yielded sensitivity from 13% to 22 % for
leptospirosis (positive predictive value range, 15e18%) and
from 8% to 19% for dengue with the conclusion that their
utility at the acute phase of dengue and leptospirosis is
limited.29
Because of their low sensitivities, use of these tests for
the initial management of acute mild leptospirosis in adults
was inferior to empirical treatment in a study conducted in
Thailand.30
The low sensitivity of these tests at the acute phase of
the disease is not related to the rapid test format but is due
to the fact that the tests detect IgM antibodies.Molecular diagnosis
The need for rapid diagnostics at the time of admission has
led to the development of numerous PCR assays. Their
advantage lies in the ability to obtain a definitive diagnosis
during the acute stage of the illness prior to antibodies are
detectable, while treatment may be effective.
PCR detects DNA in blood in the first 5e10 days after the
onset of the disease and up to the 15th day. The bacterial
load in serum/blood ranges from 105 to 109 leptospires/L.
PCR allows detection of leptospires in culture negative
blood if the patient has received an effective antimicrobial
drug but have not cleared nonviable organism.31
PCR is based on the detection of genes universally pre-
sent in bacteria as gyrB,32 rrs (16S rRNA gene),33 secY34; or
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lfb1,35 ligA, and ligB2.36
Conventional PCR assays have not been well evaluated,
leaving its diagnosis value unclear.37,38 It has been replaced
by real-time quantitative PCR (qPCR), which combines
amplification and detection of amplified product in the
same reaction vessel with excellent sensitivity and speci-
ficity and low contamination risk.39 Detection can be per-
formed using SYBR Green, which provides sensitive
detection but is less specific than detection using fluores-
cent probe technology such as TaqMan probes.
A number of qPCRs have been introduced: SYBR Green
qPCR targeting secY or lipL32; TaqMan qPCR targeting
lipL32; rss (16S); and a multiplex assay for simultaneous
detection and differentiation of pathogenic and
nonpathogenic leptospires.40
Four qPCR, SYBR green, and TaqMan assays targeting the
secY, lfb1, and lipL32 genes have been recently evaluated.
They detected from 105 bacteria/L to 106 bacteria/L of
pure culture, whole blood, plasma, and serum samples. The
authors recommend a continual evaluation and, if neces-
sary, modification of the primers and/or probes used to
ensure effective detection of the circulating leptospires
isolates. Lyophilized reagent-based PCR assay for the
detection of leptospires have been developed.41Table 2 Leptospirosis Burden Epidemiology Reference
Group definitions of leptospirosis
1. Definitive case: symptoms consistent with leptospirosis
and any one of the following:
1.1. 4-fold increase in MAT titer between acute and
convalescent serum samples
1.2. Single MAT 1:400 (or single MAT 1:100 in
nonendemic regions)
1.3. Isolation of Leptospira spp. from a normally sterile site
1.4. Detection of Leptospira spp. in clinical samples using
histological, histochemical, or immunostaining
techniques
1.5. Leptospira DNA detected by PCR
2. Presumptive case: symptoms consistent with
leptospirosis and any one of the following:
2.1. Presence of IgM antibodies, as shown by ELISA or
dipstick
2.2. Presence of IgM or IgG antibodies, as shown by
immunofluorescence assayTyping methods
Severe cases can be due to all infective serovar. Identifi-
cation is not required for clinical care but is of particular
interest from the public health perspective. It may indicate
the sources of infection and reservoirs and thus contribute
to the choice of methods for prevention and control.
Antigeneantibody reactions, such as MAT, can be used to
identify strains, but are laborious and time-consuming,
which restricts their use to specialized laboratories. In
serogroup determination the antigen suspension of the
unknown strain is used in titrations with several antisera
representing all recognized serogroups; in the cross-
agglutination-absorption test, the reaction of the un-
known strain and its antiserum is compared with reference
strains and their antisera, typing by monoclonal antibodies
is based on the recognition of antigen patterns of serovars
by panels of monoclonal antibodies.
As serotyping is complex and can only be performed in
reference laboratories, a number of molecular techniques
have been developed as alternatives to or in complement to
serotyping including: DNAeDNA hybridization, restriction
fragment length polymorphisms, pulsed-field gel electro-
phoresis, ribotyping, PCR-based typing, insertion sequences
based typing, amplification with specific primers, variable
number of tandem repeats, low-stringency single specific
primer PCR, PCR restriction endonuclease analysis, arbi-
trarily primed multiple locus sequence typing, random
amplification of polymorphic DNA, and determination of
sequences of PCR products.42
The usual target for sequence-based identification of
Leptospira species is the 16S rRNA gene.43 Other genes can
be used, such as rpoB encoding the b-subunit of RNA pol-
ymerase44e46 or gyrB encoding the b-subunit of DNA
gyrase.Susceptibility testing
Susceptibility testing is not routinely performed due to the
long incubation time required and the difficulty in quanti-
fying growth accurately.
Safety procedure
Standard microbiological laboratory safety procedures are
required when working with leptospires (Biosafety Level II
facilities).
Definition of leptospirosis
The Leptospirosis Burden Epidemiology Reference Group
definitions of leptospirosis are reported in Table 2.
The most relevant tests
Laboratory testing depends on the temporal stage of the
disease, its prevalence, the presence of a laboratory and if
present the availability of specific tests. Advantages and
disadvantages of common diagnostic tests for leptospirosis
are reported in Table 3.
Within the first days of the disease, the only sensitive
and specific test is PCR. At this stage, rapid diagnosis is only
possible if quick and easy molecular testing is possible. In
resource-restricted countries, the cost and requirement for
special equipment and technical expertise remain as bar-
riers limiting its use. As in most endemic area, molecular
testing is not available in general practice, confirmation of
the diagnosis cannot be obtained rapidly.
From the second week on the disease, serological diag-
nosis is based on the detection of specific IgM. If a labora-
tory is present, all serological tests can be performed,
expect MAT; in the absence of laboratory, rapid tests can be
performed.
Table 3 Advantages and disadvantages of common diagnostic tests for leptospirosis
Microscopic
demonstration
Culture Serology MAT Serology ELISA IgM Serology rapid
tests IgM
Molecular testing
Specimen collection Blood, urine, CSF Blood, urine, CSF,
tissues
Blood Blood Blood Blood, urine, CSF,
tissues
Window of positivity 1st wk: blood, CSF 1st 10 d From Day 10e12 From Day 6e8 From Day 6e8 From Day 5e10 in
blood2nd wk: urine
Processing time Available in 1 h 2 wk to 4 mo Several wks if not
locally available
Available in 1 d Available in
15e30 min
Available in 1 d
Early diagnosis No No No No No Yes
Definitive diagnosis
if positive
No Yes Yes (seroconversion) Yes (seroconversion) Yes (seroconversion) Yes
Identification No Yes (if MAT or
molecular testing
available)
Yes No No Yes (by additional
molecular tests)
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Laboratory diagnosis of leptospirosis: A challenge 251If the time from the onset of the illness is not indicated,
we strongly suggest that the laboratory contacts the
physician in order to perform the most relevant test: in the
1st week the negative predictive value of serology is very
low, and from the 2nd week the negative predictive value of
PCR is very low. In our laboratory we perform both tests,
and despite frequent information of the clinicians, inap-
propriate tests are prescribed and are responsible for
misdiagnosis.
The low level of concordance between PCR, MAT, and
ELISA IgM reflects the phases of the disease suggesting that
molecular and serological methods may be used in different
periods.47
Treatment should be initiated as soon as the diagnosis of
leptospirosis is suspected and preferably prior to the fifth
day after the onset of illness. Clinicians should not wait for
the results of laboratory tests prior to starting treatment.
Even tests with high sensitivity and specificity may have
limited utility in general use because of low predictive
values. The predictive value of a test varies with the
prevalence of the disease in the target population The
positive predictive value of a rapid diagnostic tests for
leptospirosis was poor at both acute and convalescent visits
because of the low prevalence of the disease in the popu-
lation of febrile patients in Thailand.
In many developing countries, including most of the
leptospirosis endemic areas, laboratory capabilities to
detect pathogenic microorganisms are often inadequate.
Sometimes, basic necessities and equipment are missing
such as electricity, refrigerators, and trained laboratory
personnel. Because of their ease of use, even in primary
health centers, rapid tests are often used in routine prac-
tice in many clinical settings. However, these rapid diag-
nostic tests may not reach optimal sensitivity until at least
a week after onset of fever, well after the time when pa-
tients first present to medical care. As the sensitivity of the
tests is low at the acute visit, these rapid diagnostic tests
should be used with caution to rule out leptospirosis, the
same restriction should be considered when using ELISA IgM
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